IGNT news

[asaaveza]

Ingen's one-of-a-kind, patented, high quality SMART Nasal Cannula solves this problem by confirming the flow of oxygen and proper equipment function at roughly the same cost as a traditional cannula. The result is lower costs for home care providers and greater peace-of-mind for in-home oxygen patients with respiratory diseases like COPD.


"Ingen's innovative oxygen cannulas are rapidly gaining traction due to their unique ability to lower costs for home care providers and provide peace-of-mind for oxygen patients," said Ingen CEO Scott Sand. "We have already booked more than $160,000 in revenues during the fourth quarter with $300,000 more in OEM orders backlogged, in addition to $1.4M in government contracts -- and we're just scratching the surface."

[Asuqytrau]

The company is proud of their capabilities in gas flow-meter technology and wireless digital data transfer of gas flow rate processing. Ingen is the first company to patent and develop transducers that detect oxygen flow rate and provide data transfer. This has revolutionized the oxygen therapy market providing user friendly solutions in monitoring oxygen levels and oxygen delivery systems.
Ingen Technologies, Inc. introduces Oxyview?, the World's First Patient In-Line Oxygen Flow-Meter. Another innovative respiratory product manufactured in the USA by Ingen Technologies; providing more confidence and assurance to patients using oxygen. Oxyview? is reusable, requires no batteries, works all the time in any position with all liquid or gas O2 systems, and easily installs anywhere below the cannula nearest the patient where oxygen flow matters the most. Oxygen suppliers and patients will appreciate that Oxyview? prevents many unnecessary service calls.
Oxygen is an element, a gas, and a drug that can help people who have certain lung diseases. The cells in the body get their energy from the interaction of oxygen with food. The energy produced is used to do everything from breathing, to carrying out bodily functions, to going to the grocery store. Some lung diseases, such as emphysema and sarcoidosis, reduce lung function to the extent that supplemental oxygen is needed to continue normal bodily function. For many people with end stage lung disease, supplemental oxygen allows their bodies to get the oxygen that they need and may also help them be more active.
To say that we need oxygen to exist is as obvious as saying we need water. But as we all know, water can also be a destructive force. The key, of course, is having the right amount in the right place at the right time. That is just as important for oxygen, especially for those who require supplementary oxygen.
An essential component to this remedy is a flow meter to ensure that the right amount of oxygen is being delivered, and just as important that it is being delivered at all. Regardless of the use of an oxymeter to measure blood gas, Oxyview? provides vital information related to functionality of the cannula and all of the oxygen equipment. If something is wrong with the cannula or equipment, the Oxyview? will show you immediately. This is usually achieved by a pneumatic flow meter, but most
that are currently on the market are expensive, attach at the tank, and are gravity-operated, which means that they only work in the vertical position with or without the cannula attached at the delivery source. In contrast, Oxyview? attaches to the cannula close to the patient— where oxygen matters the most. Oxyview? is 97 percent accurate and works hands-free in any position, whereas the conventional flow meter is less than 80 percent accurate and does not attach to the cannula.
Gravity-operated devices are also inconvenient for the patient since they must keep the tanks within sight to check the gauges for flow rate. If the tank is tilted even slightly, the gravity-operated flow meter becomes even more inaccurate and may cease functioning because friction is too great. One alternative is a digital flow meter, but these may be prohibitively expensive.

That’s why the Oxyview? flow meter (Ingen Technologies, Inc., Yucaipa, CA)is a significant advance in the technology. When first launched in November 2007, it represented a new generation of pneumatic real-time safety devices. It has some notable features: accurate to within + 3% and versatile enough to work with all respiratory equipment—CP AP, concentrators, liquid and gas cylinders, on-demand conservers and more. It is not gravity-dependent and so can be placed at any point in the tubing, even by the patients themselves. Having the device close by for easy viewing allows the patient assurance and confidence, knowing that there is a flow of oxygen at the correct level. They are also able to quickly see if the regulator or concentrator is not working properly.

[admin]

IGNT.PK looks like a prime time to grab here. imo, .0005-.0006 is the best buy. Looks like a good swing for a possible 80- 100% profit from peak of trends Double Tops @ .001 to .0011, Equity has consistant average volume spiking to 8 to 24 Million, Last three trading days has shown some relatively interesting spikes..